RedChip Companies

RedChip is the world leader in investor relations, financial media, and research for microcap and small-cap stocks. RedChip has helped hundreds of companies achieve their capital markets goals and has been ranked by Inc. Magazine as one of the fastest growing privately held investor relations firms in the U.S. #finance #capitalmarkets #investorrelations

📢 ASP Isotopes (Nasdaq: ASPI) Investor Webinar – April 8 @ 4:15PM EST Don’t miss this opportunity to hear directly from ASP Isotopes leadership about the company’s rapid progress in isotope innovation. 💡 Why It Matters to Investors: ASP Isotopes is redefining the global isotope supply chain with proprietary Quantum Enrichment tech—positioned to meet soaring demand in: 🔬 Healthcare: Commercial production of Ytterbium-176 underway—critical for cancer treatments like Novartis’ $4B+ Pluvicto. ⚛️ Clean Energy & Tech: Expansion plans for Nickel-64 and Lithium-6/7 support advanced reactors and quantum computing. 💰 Strong Financials: Debt-free balance sheet, strategically funded growth. 📍 Set your reminder now—April 8 at 4:15PM EST. 🔗 https://lnkd.in/exvZT8KW Necsa U.S. Department of Energy (DOE) TerraPower Nuclear for Climate Swiss Semiconductor Day #RedChip #RedChat #ASPIsotopes #NuclearEnergy #Isotopes #Sustainability #Investing #GreenTech

🚨 Connect Biopharma (Nasdaq: CNTB): FDA Clears Path for Dual Phase 2 Trials in Asthma & COPD Connect Biopharma received FDA alignment to launch two first-of-their-kind Phase 2 trials of rademikibart in patients immediately post-exacerbation—where no biologics are currently approved. 💡 Why It Matters • High-Need Window: Trials target 28-day post-attack period—when 45% of patients face recurrence • Fast-Acting Candidate: Prior data showed lung function boost <24 hrs after 600mg dose • Near-Term Milestones: Trials begin Q2 2025, data expected 1H 2026 • Capital Position: Cash runway extends into 2027 This could reshape care for millions at highest risk. 🔗 https://lnkd.in/ejPizhpt Biotechnology COPD Foundation Asthma + Lung UK #CNTB #Asthma #COPD #Biotech #ClinicalTrials #RespiratoryCare #Investing #finance

🚨 ASP Isotopes (Nasdaq: ASPI): Commercial Ytterbium-176 Production Begins—8 Months Ahead of Schedule ASP Isotopes has launched production of highly enriched Yb-176, a critical input for FDA-approved radiotherapies like Pluvicto ($4B+ forecast). 💡 Investor Highlights • Rare Supply Source: One of the only Western Yb-176 producers amid global shortages • Nuclear + Oncology Tailwinds: Fuels $15B+ radiopharma market & next-gen cancer drugs • Platform Expansion: Facilities for Nickel-64, Lithium-6/7, Gadolinium-160 in planning • HALEU Vision: Targeting $37B+ advanced nuclear fuel market via scalable, clean tech 📄 https://lnkd.in/ecYiQzaa Necsa U.S. Department of Energy (DOE) TerraPower Nuclear for Climate Swiss Semiconductor Day #RedChip #RedChat #ASPIsotopes #NuclearEnergy #Isotopes #Sustainability #Investing #GreenTech

🔥 Venu Holding Corp (NYSE American: VENU): March FireSuite Sales Jump 52% to $17.1M VENU posted $17.1M in March FireSuite sales, up 52% MoM—driven by strong demand and its new fractional ownership financing model. 📈 Q1 Momentum • Jan: $10.4M • Feb: $11.2M • March: $17.1M ➡️ Tracking toward $200M in 2025 💡 Why It Matters ✅ FY24 FireSuite sales up 250% YoY to $77.7M ✅ Financing lowers entry barriers, expands buyer base ✅ National rollout underway in TX & OK markets 📄 https://lnkd.in/eq9SaE-6 JW Roth Troy Aikman EIGHT Elite Light Lager AEG Real Estate #VenuLive #RedChip #RedChat #IncomeFund #AlternativeInvestments #LiveEntertainment #Hospitality

🎶 Alliance Entertainment (Nasdaq: AENT) Powering Record Store Day with 650K+ Records Shipped Alliance Entertainment is the #1 distributor for Record Store Day 2025, shipping ~650K units (+8.3% YoY) across 1,500+ indie stores nationwide—driven by 330+ exclusive titles. 💡 Why It Matters 📈 Vinyl demand up 10.7% YoY (RIAA) 🎯 AMPED Distribution adds 100K units from 67 exclusive titles 🎧 Gen Z traction with top artists (Taylor Swift, Charli XCX, Laufey) 🔗 https://lnkd.in/eUw__YeT #RedChip #RedChat #AENT #Retail #Investing #Finance #VinylRevival #RecordStoreDay #MusicIndustry

🚨 OS Therapies (NYSE American: OSTX) Major Regulatory Catalyst in 2025 OST-HER2 data readout (June) from Phase 2b osteosarcoma trial sets stage for BLA submission and potential Priority Review Voucher—a monetizable asset. 🔑 Investor Highlights • FDA Breakthrough Therapy Designation & PRV targeted post-June • Cash runway into 2026, post-trial burn rate drops • Pipeline expansion via Ayala deal adds Phase 1/2 immuno-oncology assets (lung, prostate) • Commercial manufacturing of OST-HER2 underway OST-HER2 has shown statistically significant gains in 12-month event-free survival for a rare pediatric cancer. Regulatory filings in U.S. & Europe planned. 📄 https://lnkd.in/e_v7DjxZ #RedChip #RedChat #OSTX #BiotechStocks #Immunotherapy #ADC #Investing #CancerResearch #StockMarket

🧬 Calidi Biotherapeutics (NYSE American: CLDI) Advancing Multi-Platform Cancer Immunotherapies Q4/FY24 highlights strong progress across 3 oncology programs: ✅ CLD-400: Preclinical success in tumor-targeted gene delivery—payload reveal Q2 ✅ CLD-201: IND filed (March) for solid tumor Phase 1 (breast, H&N, sarcoma) ✅ CLD-101: Glioma trials advancing at Northwestern University & City of Hope (14 dosed, $12M CIRM funding) 📉 Financials • Net loss down to $23.8M (vs. $29.2M) • R&D/G&A sharply reduced • Cash up to $9.6M 🔜 2025 Milestones: First patient dosing (CLD-101 & CLD-201), CLD-400 payload reveal 📄 https://lnkd.in/ey6-CQpq California Institute for Regenerative Medicine (CIRM) The Lancet Group #RedChip #RedChat #CalidiBio #BiotechStocks #Oncology #InvestorUpdate #CancerResearch #FinancialNews

🎤 VENU (NYSE American: VENU) Delivers a Hit Performance in 2024 - Triple-Digit Asset Growth, Blockbuster Sales, and Fan-Fueled Momentum VENU ended 2024 with strong momentum in assets, revenue, and operations across its premium entertainment portfolio: 📊 Financial Highlights • Assets: ↑114% YoY to $178.4M • Revenue: ↑42% to $17.8M • FireSuite Sales: +250% to $77.7M • Ford Amphitheater: $15.2M gross from just 20 shows 🚀 Strategic Wins • IPO raised $12.3M • Opened Ford Amphitheater (112K+ fans, Pollstar-nominated) • Broke ground on 3 new large-scale venues (TX, OK) • Launched income/financing programs to fuel FireSuite scale 🔗 https://lnkd.in/egjpBq9z Troy Aikman EIGHT Elite Light Lager AEG Real Estate #VenuLive #RedChip #RedChat #IncomeFund #AlternativeInvestments #PrivateEquity #LiveEntertainment #AccreditedInvestors #Hospitality

💨 Connect Biopharma (Nasdaq: CNTB): New Phase 2 Data Spotlights Rademikibart as a Standout Asthma Biologic Positive results published in AJRCCM show: 📈 +420 mL FEV₁ Gain in high eosinophil patients—among the best seen with any biologic ⚡ Rapid Onset: Significant improvement by Week 1, sustained through 24 weeks 📉 Exacerbation Drop: Fewer events despite 2x patient count vs. placebo 🛡️ Clean Safety Profile: No hypereosinophilia—key edge over dupilumab 🔬 Why It Matters: With FDA clearance to enter Phase 3 and >2M U.S. patients facing exacerbations annually, Connect Biopharma could emerge as a major contender in the $20B+ asthma/COPD biologics market. 📄 Full PR: https://lnkd.in/em6nN4RZ #CNTB #Asthma #COPD #Biotech #ClinicalTrials #RespiratoryCare #Investing #finance